How Marques was paid
$1.3M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Options | Other | Total |
|---|---|---|---|---|---|
| Tiago Reis MarquesChief Executive Officer | $533,610 | $493,150 | $277,258 | $23,500 | $1,327,518 |
| Daniel SchneidermanChief Financial Officer | $386,984 | $306,400 | $178,303 | $23,500 | $895,187 |
| Graeme CurrieChief Development Officer | — | — | — | — | — |
What changed and why
- $1.3M$1,327,518 was CEO total compensation in 2025, versus $640,059 in 2024.
- $277K$277,258 in CEO option awards represented options to purchase 493,341 shares.
- $23,500$23,500 in CEO and CFO compensation reflected 401(k) matching contributions.
- 55%55% of the CEO's annual base salary was the current target bonus percentage.
- 40%40% of the CFO's annual base salary was the current target bonus percentage.
- $621K$621,000 was the CEO's annual base salary effective January 1, 2026.
Other Pasithea Therapeutics proxy statements
- 2025 proxy statement
Tiago Reis Marques paid $640,059 (+19% on the year).
Filed Dec 29, 2025
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.